Kevin A. Schulman, MD, MBA serves as a professor of medicine at Duke University.

At Duke, he is a faculty associate director of the Duke Clinical Research Institute (DCRI) at the School of Medicine. At 1200 faculty and staff, the DCRI is the country’s largest academic clinical research organization. His other university affiliations include the Trent Center for Bioethics, Humanities and History of Medicine; the Duke Translational Research Institute; and he previously served on the Executive Committee of the Duke Global Health Institute.

At Duke’s Fuqua School of Business, Dr. Schulman oversaw the growth of what has become the country’s largest health sector management program at any top business school. He served as the Gregory Mario and Jeremy Mario Professor of Business Administration, director of the Health Sector Management Program (HSM), and the Center for the Study of Health Management for over a dozen years. During this time, he graduated almost 1500 students with a Certificate in Health Sector Management.

He is the Founding Director of the unique Master of Management in Clinical Informatics program (MMCi), originally offered through the Fuqua School of Business and now housed in the Duke University School of Medicine.

He has served as a Visiting Professor in General Management at Harvard Business School from 2013-2016, and is currently a Visiting Scholar at the School.  This appointment serves as a part of the HBS Health Care Initiative.  At HBS, he has co-taught Innovating in Health Care with professor Regina Herzlinger 2013-2015, and wrote and taught Innovating in Biomedical Technology in 2014.

He is the Founding President of the Business School Alliance for Health Management (http://www.BAHM-Alliance.Org), which is a consortium of the leading business schools offering health management programs.  He is a founding member of the Global Educators Network for Health Care Innovation and Entrepreneurship (GENIE) Group (www.thegeniegroup.org). 

He regularly teaches courses in biotechnology (including for the FDA Commissioner’s Fellows Program), healthcare innovation, healthcare biomedical technology, health IT and strategy, and global health care systems.

Dr. Schulman’s research interests include organizational innovation in health care, health care policy and health economics.  Dr. Schulman has published over 400 papers, book chapter, and business case studies. His peer-reviewed articles have appeared in the New England Journal of Medicine, JAMA, and Annals of Internal Medicine. He is a member of the editorial/advisory boards of the American Heart Journal, Health Policy, Management and Innovation (www.HMPI.Org), and Senior Associate Editor of Health Services Research.

Dr. Schulman is a co-founder of Bivarus, a novel survey platform to assess the patient experience in care (www.Bivarus.com); Series A funded by Excelerate Ventures); is a founder of Faculty Connections, LLC, a consulting services company; a founder of PELI, LLC, an on-line physician leadership program acquired by Duke University and marketed by Medscape as the Business of Healthcare Academy, was a Board member of Anthelio, Inc, an IT services company, is a Board Member of Cue Biologics, an immune-oncology company spun out of Duke University, and served on the Scientific Advisory Board of the Nutrition Sciences Initiative (www.NUSI.org). He is a member of the Advisory Board for the Kaiser Permanente Institute for Health Policy. 

He is a graduate of Dartmouth College, the NYU School of Medicine, and the Wharton Health Care Management Program.  

This event is free and open to the public, but please register.